Alpha Cognition Inc

Research Alpha Cognition Inc (ACOG) on Bullrun: market cap USD 148.28M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerACOG
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 148.28M
• Financial periodFY2025
• RevenueUSD 10.22M
• Net income-USD 20.67M
• Free cash flow-USD 20.67M
• Gross margin94.1%

Valuation Snapshot

latest market cap is USD 148.28M.

About Alpha Cognition Inc

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation;

Frequently asked questions

What is Alpha Cognition Inc's market cap?

Alpha Cognition Inc's market capitalization is USD 148.28M.

What does Alpha Cognition Inc do?

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.